Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Stimulation Device Helps Patients with Bladder Disorders ReprogramStimulation Device Helps Patients with Bladder Disorders Reprogram


 
Melissa Kaufman, MD, PhD, FACS

A neurostimulator surgically implanted above the buttocks to reprogram how the bladder senses the filling of urine is helping patients with debilitating bladder and bowel disorders that are often life-limiting.

It is estimated that over 37 million American men and women suffer from incontinence, which translates to almost one-in-six people. It can be brought on by a number of factors including hormone loss, a back injury or pelvic surgery in the area.

"Ninety percent of patients who have urgency incontinence (leakage), report isolation, depression and even hopelessness," said Melissa Kaufman, MD, PhD, FACS, Professor of Urology and Chief, Division of Reconstructive Urology and Pelvic Health at Vanderbilt University Medical Center (VUMC).

"And the stigma around this is a very real entity. Patients are reticent to discuss it with their providers and therefore are undertreated. I have patients who have lost the capacity to go about any of their normal daily activities and avoid any company because of their fear of leakage.

Kaufman said that VUMC is joining the ELITE clinical study of InterStimTM Micro - the newest model of an existing technology used to help treat patients suffering with bladder and bowel disorders. Up to 40 centers will be enrolled to study 200 patients over a two-year period.

The new model is upgraded with a rechargeable battery and full-body MRI compatibility. The technology was approved by the FDA in 1997, but older devices have to be removed before most MRI procedures.

"Very, very few patients are offered advanced therapies and what we are able to accomplish at Vanderbilt is offer patients who have failed behavioral and medical therapies an opportunity to regain their quality of life," Kaufman said.

"We offer treatments such as the InterStim to provide a way for the bladder to reprogram how it senses filling and storage of urine to reduce the episodes of urgency incontinence for the patient. It is an exceptionally powerful technology and the ELITE study is one of several clinical trials for these devices that we have been involved in through the years."

Kaufman, Stuart Reynolds, MD, MPH, associate professor of Urology, and Roger Dmochowski, MD, MMHC, professor of Urology and VUMC associate surgeon-in-chief, have implanted neurostimulators in patients to treat this condition several hundred times over the last two decades, averaging 10-15 per month.

The surgery to have the device implanted is an outpatient procedure and the recovery is straightforward for most patients, Kaufman said.

There are two small incisions less than a few inches on the back where the device is installed near the sacrum, on the top of the buttocks, so it is not actually near the bladder. It leads out into the peripheral nerves that provide signaling to the bladder.

Many patients use pain medication for a few days after the surgery and are asked to avoid any strenuous activity for several weeks

"Neuromodulation represents one of the most promising developments in pelvic floor medicine in the last two decades," Dmochowski said. "This treatment modality continues to evolve and become much more patient focused. The benefit to patients suffering with these conditions is immense."

 
Share:

Related Articles:


Recent Articles

Tennessee Rare Disease Advisory Council to Inform TennCARE on Pharmaceutical Treatments

Council will advise and address impact of rare diseases on Tennesseans

Read More

Medical Groups Urge CMS to Walk Back ACO Quality Overhaul

Letter Signed by Eleven Organizations to Biden Administration

Read More

Google Chief Health Officer Dr. Karen DeSalvo Addresses Health Care Council

On behalf of the Nashville Health Care Council, Sen. Bill Frist, MD, and Google Chief Health Officer Karen DeSalvo, MD, shared a conversation on the tech company's role in healthcare.

Read More

NCI Director Updates Cancer Progress

In April, NCI Director Ned Sharpless, MD, FAACR, addressed the AACR Annual Meeting to provide an update on where we stand in the fight against cancer.

Read More

No Surprises: Federal Legislation Addresses Balance Billing

Read More

Construction, Design & Real Estate Rounds

Read More

Blakeford Expansion Focuses on Form, Function & Fun

Blakeford at Green Hills is in the midst of a major campus expansion and renovation to rethink senior living.

Read More

First-Year Data on TNPSQ Mental Health Screening Tool

An anonymous online mental health screening tool for Tennessee health professionals saw higher-than-expected s in its first year.

Read More

Acadia Healthcare CEO Discusses COVID & Mental Health

In the latest installment of the Nashville Health Care Council's Brass Tacks series, Acadia CEO Debbie Osteen discusses the toll COVID-19 has taken on mental health.

Read More

Celebrating the Annual Dr. Matthew Walker, Sr., Legacy Breakfast

The annual event, a fundraiser for the Matthew Walker Comprehensive Health Center, drew more than 340 virtual attendees for a morning of celebration.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: